This country profile provides an overview of Rwanda’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
99%
Bilharzia
70%
River blindness
N/A
4.09 million
people received treatment in Rwanda in 2019
931k
people did not receive treatment in Rwanda in 2019
Elephantiasis
Rwanda does not require mass treatment for elephantiasis.
Blinding trachoma
Rwanda does not require mass treatment for blinding trachoma.
Intestinal worms
Treatment coverage remained at 99% in 2018 and 2019.
Pre-sch and school-aged children needing treatment
3.99m
Pre-school and school-aged children receiving treatment
3.95m
Bilharzia
Treatment coverage decreased from 73% in 2018 to 70% in 2019.
School-aged children needing treatment
1.62m
School-aged children receiving treatment
1.14m
River blindness
Rwanda does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Rwanda.